Washington, DC 20549







Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934


August 12. 2019

Date of Report (date of earliest event reported)



Cutera, Inc.

(Exact name of Registrant as specified in its charter)









(State or other jurisdiction of

incorporation or organization)


(Commission File Number)


(I.R.S. Employer

Identification Number)


3240 Bayshore Blvd.

Brisbane, California 94005

(Address of principal executive offices)


(415) 657-5500

(Registrant’s telephone number, including area code)



(Former name or former address, if changed since last report)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):


Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Securities registered pursuant to Section 12(b) of the Act:


Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock ($0.001 par value)


The NASDAQ Stock Market, LLC


Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).


Emerging growth company    ☐


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐





Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


On August 12, 2019, Dr. David B. Apfelberg, age 77, notified the board of directors (“Board”) of Cutera, Inc. (the “Company”) that he intends to retire from the Board effective at the end of his current term, which expires on the date of the Company’s 2020 Annual Meeting of Stockholders expected to be held in June 2020. Dr. Apfelberg’s decision to resign does not arise from any disagreement on any matter relating to the Company’s operations, policies, practices, or regarding the general direction of the Company.


The Nominating and Governance Committee of the Board will begin actively searching for qualified director candidates to serve on the Company’s Board.


Additional information about the Board changes described above is included in the Company’s press release issued on August 12, 2019, which is attached as Exhibit 99.1 to this Current Report on Form 8-K.



Item 9.01 Exhibits.


Exhibit No.



Press Release dated August 12, 2019 announcing the retirement of David B. Apfelberg from the Cutera, Inc. Board of Directors effective at the end of his current term.







Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.







Date: August 12, 2019

/s/ Darren W. Alch


Darren W. Alch 


Vice President, General Counsel & Corporate Secretary





Exhibit 99.1






Cutera Announces Planned Retirement of David B. Apfelberg, M.D.,

as Member of the Board of Directors



BRISBANE, California, August 12, 2019 ─ Cutera, Inc. (CUTR) (“Cutera” or the “Company”), a leading provider of laser and energy-based aesthetic systems for practitioners worldwide, today announced that David B. Apfelberg, M.D., age 77, has notified the Board of Directors of the Company (the “Board”) that he intends to retire from the Board at the expiration of his current term in June 2020.


“With new leadership in place at Cutera, it is the right time for me to communicate my intention to step aside at the next annual meeting,” commented Dr. Apfelberg. “I am fortunate to have served on the Cutera Board for over 20 years, and am confident as I transition my Board seat that the Company is well positioned moving forward. I endorse the efforts of new CEO Dave Mowry, the rest of the management team and the Board without qualification.”


Dr. Apfelberg notified the Board that he intends to serve out his current term and support the search for a replacement. Dr. Apfelberg currently serves on the Board’s Compensation Committee as well as the Nominating and Corporate Governance Committee. The Nominating and Governance Committee will begin the process of identifying and evaluating director candidates to fill the vacancy.


“On behalf of all Cutera stakeholders, I thank Dave for his two decades of valuable service to the Company,” commented J. Daniel Plants, Cutera’s Chairman. “His intense passion for Cutera’s products, people and customers have contributed meaningfully to the Company’s success. Dave will be missed, and we wish him the very best in his retirement.”


About Cutera, Inc.

Brisbane, California-based Cutera is a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit


This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. The forward-looking statements include plans for the director search process. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties, which may cause Cutera's actual results to differ materially from the statements contained herein. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements. There are a number of risks, uncertainties and other important factors, many of which are beyond our control, that could cause our actual results to differ materially from the forward-looking statements contained in this press release, including those described in the “Risk Factors” section of Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, the Registration Statement on Form S-8 and other documents filed from time to time with the United States Securities and Exchange Commission by Cutera. Forward-looking statements speak only as of the date they are made. Cutera undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.

Cutera, Inc.


Matthew Scalo


VP, Investor Relations and Corporate Development






# # #